Kamada (KMDA) continues to expect to generate fiscal year 2025 total revenues in the range of $178 million to $182 million, and adjusted EBITDA in the range of $38 million to $42 million, representing a year-over-year increase of approximately 12% in revenues and 17% in adjusted EBITDA based on the mid-point of the 2025 guidance.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KMDA:
- Kamada to Release Q1 2025 Financial Results on May 14
- Kamada Launches Post-Marketing Research Program for CYTOGAM
- Kamada announces launch of post-marketing research program for CYTOGAM
- Kamada Announces Tax Ruling on Special Cash Dividend
- Kamada provides update on withholding tax procedures on special cash dividend